| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6454c0662d021234221736815939a30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_649d92f2fb0933e6c14e7f862b0b6331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_625ef9e77869331e8e4e79ce5ae6aff5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef97b3c241fe5898a93f21df256545bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02 |
| filingDate |
2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c282ec848205faf5555a8ad00846e7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b00dd6b94b4fb13b5e2d9cfe25993abf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da56ccf8952775b4579f8db1354cfbd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_376585f393660b2397b21d9e6655c5bf |
| publicationDate |
2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8603513-B2 |
| titleOfInvention |
Article comprising calcium for reducing the production of TSST-1 |
| abstract |
Articles comprising one or more calcium salts are provided. The articles can contain one or more calcium salts in an amount effective to reduce the production of TSST-1 by at least about 50% when measured by the Shake Flask Method. In certain embodiments, the one or more calcium salts can be substantially non-lethal to Staphylococcus aureus when measured by the Shake Flask Method, and/or to Lactobacillus crispatus, Lactobacillus gasseri , and/or Lactobacillus iners when measured by the Maximum Tolerated Dose Test. |
| priorityDate |
2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |